ARMC
LGND icon

American Research & Management Company’s Ligand Pharmaceuticals LGND Stock Holding History

American Research & Management Company’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-40
Closed -$2K – 373
2015
Q3 		$2K Hold
40
– – ﹤0.01% 351
2015
Q2 		$3K Hold
40
– – ﹤0.01% 350
2015
Q1 		$2K Hold
40
– – ﹤0.01% 344
2014
Q4 		$1K Buy
+40
New +$1.3K ﹤0.01% 353

Other funds holding LGND

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

American Research & Management Company's LGND Position: Q4 2015 in Review

American Research & Management Company sold out of Ligand Pharmaceuticals (LGND) in Q4 2015, closing a stake of 40 shares — an estimated $2K sold.

American Research & Management Company first reported a position in LGND in Q4 2014 and held it in 4 quarters. The position peaked at $3K in Q2 2015. 233 funds tracked by Wall St. Rank hold LGND as of Q4 2015.

  • American Research & Management Company reported no remaining Ligand Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • American Research & Management Company sold 40 Ligand Pharmaceuticals shares in Q4 2015, an estimated $2K.
  • American Research & Management Company first reported a position in Ligand Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • American Research & Management Company's Ligand Pharmaceuticals position peaked at $3K in Q2 2015.
  • 233 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q4 2015.

Based on American Research & Management Company's 13F filing for Q4 2015, filed 22 Jan 2016.